Aker BioMarine ASA – Notice of Extraordinary General Meeting
17 July 2026: An extraordinary general meeting of Aker BioMarine ASA will be held on 17 August 2026 at 09:00 CEST.
The meeting will be conducted as a virtual meeting only, and voting will be handled online during the meeting. Information about log-in details for the meeting is available in the notice of the general meeting. For further information regarding participation, please go to www.akerbiomarine/agm.
No pre-registration is needed for attending online, but attendees must be logged in before the meeting starts. Deadline for registration of advance votes and proxies is 14 August 2026 at 16:00 CEST.
Please find attached the following documents
- Notice and Proxy forms for the Extraordinary General Meeting
- Proposed Resolutions for the Extraordinary General Meeting
All documents to be processed in the meeting are available on www.akerbiomarine/agm.
For further information, please contact
Lars Jacobsen, General Counsel Mobile: +47 906 05 306
Email: lars.jacobsen@akerbiomarine.com
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.
About Aker BioMarine Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.